Lipoprotein, especially low-density lipoprotein (LDL), is an important risk factor for cardiovascular disease. LDL contributes to the atherogenic process, in part, by causing endothelial vasodilatory dysfunction and activation. Therefore, understanding how LDL alters endothelial function is an important problem in cardiovascular disease. Endothelial vasodilatory function and activation are regulated by endothelium-derived nitric oxide (NO), and evidence suggests that endothelium-derived NO attenuates atherogenesis and vascular inflammation. Previous work supported by this grant have shown that LDL attenuates endothelial NO synthase (eNOS) activity via effects on heterotrimeric and small guanine nucleotide-binding proteins (G proteins). Furthermore, the HMG-CoA reductase inhibitors or statins improve endothelial vasodilatory function, in part, by inhibiting the isoprenylation of the small G protein, Rho. These findings, therefore, form the basis of our hypothesis that heterotrimeric and small G proteins play an important role in mediating LDL-induced endothelial cell dysfunction and activation. The precise mechanism by which LDL modulates G protein function, however, is not known. The overall goal of this grant proposal, therefore, is to investigate the mechanism by which lipoproteins and statins regulate endothelial G protein function and to correlate these effects with functional changes in receptor-mediated eNOS activity and lipoprotein-induced endothelial cell activation. In this competitive renewal application, we have proposed 4 specific aims, which will extend our previous studies on LDL's effect on G proteins and eNOS.
In specific aim 1, we will test the hypothesis that inhibition of G proteins by LDL is mediated by regulators of G-protein signaling (RGS).
In specific aim 2, we will determine whether statins can reverse LDL's inhibitory effect on G proteins by cholesterol-independent mechanism.
In specific aim 3, we will test the hypothesis that lipoproteins downregulate eNOS expression and activity by activating Rho-mediated pathways. Finally, in specific aim 4, we will test the functional significance of statin-induced eNOS activation by investigating the effects of statin on LDL-induced endothelial cell activation. These proposed studies will hopefully provide greater insights into how lipoproteins cause endothelial dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL052233-07
Application #
6537127
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Rabadan-Diehl, Cristina
Project Start
1995-07-01
Project End
2005-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
7
Fiscal Year
2002
Total Cost
$431,667
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Hiroi, Yukio; Noma, Kensuke; Kim, Hyung-Hwan et al. (2018) Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice. Circ J 82:1195-1204
Liao, James K; Oesterle, Adam (2018) The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol :
Tabit, Corey E; Coplan, Mitchell J; Chen, Phetcharat et al. (2018) Tumor necrosis factor-? levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant 37:107-115
Tabit, Corey E; Coplan, Mitchell J; Spencer, Kirk T et al. (2017) Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure. Am J Med 130:1112.e17-1112.e31
Sladojevic, Nikola; Oh, Goo Taeg; Kim, Hyung-Hwan et al. (2017) Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. Cardiovasc Res 113:1307-1317
Kasahara, D I; Mathews, J A; Ninin, F M C et al. (2017) Role of ROCK2 in CD4+ cells in allergic airways responses in mice. Clin Exp Allergy 47:224-235
Shimizu, Toru; Narang, Nikhil; Chen, Phetcharat et al. (2017) Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. JCI Insight 2:
Sladojevic, Nikola; Yu, Brian; Liao, James K (2017) ROCK as a therapeutic target for ischemic stroke. Expert Rev Neurother 17:1167-1177
Mazurek, Stefan; Kim, Gene H (2017) Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy. Biochim Biophys Acta Mol Basis Dis 1863:2064-2069
Oesterle, Adam; Laufs, Ulrich; Liao, James K (2017) Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res 120:229-243

Showing the most recent 10 out of 150 publications